Stockreport

What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer. [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF In recent times, this has proven to be GLP-1 drugs, treatments that have helped patients worldwide safely and rather quickly lose weight. Eli Lilly and Novo Nordisk , an [Read more]